BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003;362:2089-2094. [PMID: 14697813 DOI: 10.1016/s0140-6736(03)15108-2] [Cited by in Crossref: 563] [Cited by in F6Publishing: 198] [Article Influence: 31.3] [Reference Citation Analysis]
Number Citing Articles
1 Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of “a” determinant variants. J Virol. 2006;80:2968-2975. [PMID: 16501106 DOI: 10.1128/jvi.80.6.2968-2975.2006] [Cited by in Crossref: 116] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
2 Honda K, Seike M, Murakami K. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis. World J Hepatol 2015; 7(22): 2404-2410 [PMID: 26464756 DOI: 10.4254/wjh.v7.i22.2404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
3 Calabrese LH, Zein NN, Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis. 2006;65:983-989. [PMID: 16627542 DOI: 10.1136/ard.2005.043257] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 9.4] [Reference Citation Analysis]
4 Ren FY, Jin H, Piao XX, Piao FS. Ribavirin and IFN-α combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B. World J Gastroenterol 2007; 13(41): 5440-5445 [PMID: 17907286 DOI: 10.3748/wjg.v13.i41.5440] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chang PY, Huang CC, Hung CH, Yu CY, Wu DK, Hwang JI, Liang PC, Wu RH, Tsai WL, Lin YJ, Liu YS, Liang HL, Lee RC, Chen CH. Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer 2018;7:312-22. [PMID: 30488021 DOI: 10.1159/000487608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kondo Y, Ueno Y, Shimosegawa T. Toll-like receptors signaling contributes to immunopathogenesis of HBV infection. Gastroenterol Res Pract. 2011;2011:810939. [PMID: 22190911 DOI: 10.1155/2011/810939] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wong GL. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 2014;20:228-36. [PMID: 25320725 DOI: 10.3350/cmh.2014.20.3.228] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
8 Han SX, Jia X, Ma JL, Zhu Q. Molecular beacons: a novel optical diagnostic tool. Arch Immunol Ther Exp (Warsz) 2013;61:139-48. [PMID: 23292078 DOI: 10.1007/s00005-012-0209-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
9 Li L, Shen H, Li A, Zhang Z, Wang B, Wang J, Zheng X, Wu J, Yang D, Lu M. Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B. Virol J. 2013;10:214. [PMID: 23805945 DOI: 10.1186/1743-422x-10-214] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
10 Wang J, Lian Y, Gu Y, Wang H, Gu L, Huang Y, Zhou L, Huang Y. Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells. Oncotarget 2017;8:105047-60. [PMID: 29285232 DOI: 10.18632/oncotarget.22086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Muttil P, Prego C, Garcia-Contreras L, Pulliam B, Fallon JK, Wang C, Hickey AJ, Edwards D. Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary route. AAPS J 2010;12:330-7. [PMID: 20419360 DOI: 10.1208/s12248-010-9192-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
12 Nakamuta M, Kotoh K, Enjoji M, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Tanabe Y, Hayashi J. Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients. Comp Hepatol 2007;6:3. [PMID: 17470300 DOI: 10.1186/1476-5926-6-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Cheung F, Feng Y, Wang N, Yuen MF, Tong Y, Wong VT. Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials. Chin Med 2012;7:5. [PMID: 22376935 DOI: 10.1186/1749-8546-7-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
14 Li MS, Lau TC, Chan SK, Wong CH, Ng PK, Sung JJ, Chan HL, Tsui SK. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. PLoS One. 2011;6:e21856. [PMID: 21814558 DOI: 10.1371/journal.pone.0021856] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
15 Su M, Guo J, Huang J. Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma. Clin Mol Hepatol 2017;23:138-46. [PMID: 28427253 DOI: 10.3350/cmh.2016.0083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol 2015; 7(12): 1708-1717 [PMID: 26140091 DOI: 10.4254/wjh.v7.i12.1708] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
17 Ahn SH, Park YK, Park ES, Kim JH, Kim DH, Lim KH, Jang MS, Choe WH, Ko SY, Sung IK. The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene. J Virol. 2014;88:6805-6818. [PMID: 24696492 DOI: 10.1128/jvi.00635-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
18 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
19 Zhu X, Chen L, Fan W, Lin MC, Tian L, Wang M, Lin S, Wang Z, Zhang J, Wang J. An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers. PLoS One. 2011;6:e21997. [PMID: 21779363 DOI: 10.1371/journal.pone.0021997] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
20 Suzuki F, Suzuki Y, Karino Y, Tanaka Y, Kurosaki M, Yatsuhashi H, Atarashi T, Atsukawa M, Watanabe T, Enomoto M, Kudo M, Maeda N, Kohno H, Joko K, Michitaka K, Miki K, Takahashi K, Ide T, Fujiyama S, Kohno T, Itoh H, Tsukamoto S, Suzuki Y, Kawano Y, Sugiura W, Kumada H. Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study. BMC Gastroenterol 2021;21:489. [PMID: 34930140 DOI: 10.1186/s12876-021-02008-9] [Reference Citation Analysis]
21 Grant J, Agbaji O, Kramvis A, Yousif M, Auwal M, Penugonda S, Ugoagwu P, Murphy R, Hawkins C. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians. Trop Med Int Health 2017;22:744-54. [PMID: 28376292 DOI: 10.1111/tmi.12873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Gong J, Zhu C, Zhuang R, Song C, Li Q, Xu Z, Wei Y, Yang K, Yang A, Chen L, Jin B. Establishment of an enzyme-linked immunosorbent assay system for determining soluble CD96 and its application in the measurement of sCD96 in patients with viral hepatitis B and hepatic cirrhosis. Clin Exp Immunol 2009;155:207-15. [PMID: 19040604 DOI: 10.1111/j.1365-2249.2008.03829.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
23 Inuzuka T, Takahashi K, Chiba T, Marusawa H. Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions. Pathogens. 2014;3:377-389. [PMID: 25437805 DOI: 10.3390/pathogens3020377] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
24 Abdo AA, Al-Jarallah BM, Sanai FM, Hersi AS, Al-Swat K, Azzam NA, Al-Dukhayil M, Al-Maarik A, Al-Faleh FZ. Hepatitis B genotypes: Relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 2006; 12(43): 7019-7024 [PMID: 17109498 DOI: 10.3748/wjg.v12.i43.7019] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
25 Aljarbou AN. The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia. Int J Health Sci (Qassim) 2013;7:333-40. [PMID: 24533027 DOI: 10.12816/0006062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wong DK, Tanaka Y, Lai CL, Mizokami M, Fung J, Yuen MF. Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection. J Clin Microbiol. 2007;45:3942-3947. [PMID: 17942661 DOI: 10.1128/jcm.00366-07] [Cited by in Crossref: 108] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
27 Henkel C, Schwamborn K, Zimmermann HW, Tacke F, Kühnen E, Odenthal M, Groseclose MR, Caprioli RM, Weiskirchen R. From proteomic multimarker profiling to interesting proteins: thymosin-β(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions. J Cell Mol Med 2011;15:2176-88. [PMID: 21496200 DOI: 10.1111/j.1582-4934.2010.01204.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
28 Rudin D, Shah SM, Kiss A, Wetz RV, Sottile VM. Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials. Liver Int 2007;27:1185-93. [PMID: 17919229 DOI: 10.1111/j.1478-3231.2007.01580.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
29 Shi M, Sun WL, Hua YY, Han B, Shi L. Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B. PLoS One. 2015;10:e0117741. [PMID: 25647607 DOI: 10.1371/journal.pone.0117741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
30 Yang SG, Wang B, Chen P, Yu CB, Deng M, Yao J, Zhu CX, Ren JJ, Wu W, Ju B, Shen JF, Chen Y, Li MD, Ruan B, Li L. Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation. PLoS One 2012;7:e47808. [PMID: 23094094 DOI: 10.1371/journal.pone.0047808] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
31 Wang Y, Mo Y, Wang L, Su P, Xie Y. Let-7b contributes to hepatocellular cancer progression through Wnt/β-catenin signaling. Saudi J Biol Sci 2018;25:953-8. [PMID: 30108446 DOI: 10.1016/j.sjbs.2018.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Qian WP, Tan YQ, Chen Y, Peng Y, Li Z, Lu GX, Lin MC, Kung HF, He ML, Shing LK. Rapid quantification of semen hepatitis B virus DNA by real-time polymerase chain reaction. World J Gastroenterol 2005; 11(34): 5385-5389 [PMID: 16149152 DOI: 10.3748/wjg.v11.i34.5385] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
33 Nakamuta M, Morizono S, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Kotoh K, Enjoji M, Hayashi J; Kyushu University Liver Disease Study Group. Relationship between body surface area and ALT normalization after long-term lamivudine treatment. World J Gastroenterol 2005;11:6948-53. [PMID: 16437598 DOI: 10.3748/wjg.v11.i44.6948] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Shen YY, Hou W, Yang ZQ, Xiao W. Hepatitis B virus infection and genotype in asymptomatic people from 10 ethnic groups in Yunnan, China. World J Gastroenterol 2015; 21(44): 12586-12592 [PMID: 26640334 DOI: 10.3748/wjg.v21.i44.12586] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
35 Liao Y, Cai B, Li Y, Chen J, Tao C, Huang H, Wang L. Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis. PLoS One. 2014;9:e111677. [PMID: 25365208 DOI: 10.1371/journal.pone.0111677] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
36 Vincent IE, Zannetti C, Lucifora J, Norder H, Protzer U, Hainaut P, Zoulim F, Tommasino M, Trépo C, Hasan U. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One. 2011;6:e26315. [PMID: 22046272 DOI: 10.1371/journal.pone.0026315] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
37 Hawkins C, Agbaji O, Ugoagwu P, Thio CL, Auwal MM, Ani C, Okafo C, Wallender E, Murphy RL. Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria. Clin Infect Dis 2013;57:e189-92. [PMID: 24014732 DOI: 10.1093/cid/cit564] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
38 Meng S, Zhan S, Li J. Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays. Virol J 2009;6:226. [PMID: 20025781 DOI: 10.1186/1743-422X-6-226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
39 Kim NH, Cho YK, Kim BI, Kim HJ. Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment. Dig Dis Sci 2018;63:2792-9. [PMID: 29948568 DOI: 10.1007/s10620-018-5165-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
40 Lu YP, Guo T, Wang BJ, Dong JH, Zhu JF, Liu Z, Lu MJ, Yang DL. Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients. World J Gastroenterol 2008; 14(22): 3490-3496 [PMID: 18567076 DOI: 10.3748/wjg.14.3490] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Huang C, Lin HH, Wan JB, He C, Hu Y. Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations. PLoS One 2016;11:e0164328. [PMID: 27727319 DOI: 10.1371/journal.pone.0164328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
42 Qiu N, Li R, Yu JG, Yang W, Zhang W, An Y, Li T, Liu XE, Zhuang H. Comparison of Abbott and Da-an real-time PCR for quantitating serum HBV DNA. World J Gastroenterol 2014; 20(33): 11762-11769 [PMID: 25206280 DOI: 10.3748/wjg.v20.i33.11762] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
43 Karimi A, Salimzadeh L, Bagheri N. Hepatitis B virus genotyping among chronic hepatitis B individuals with resistance to Lamivudine in shahrekord, iran. Jundishapur J Microbiol 2014;7:e10196. [PMID: 25147693 DOI: 10.5812/jjm.10196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
44 Wheelhouse NM, Lai PB, Wigmore SJ, Ross JA, Harrison DJ. Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver. Br J Cancer. 2005;92:1268-1272. [PMID: 15785740 DOI: 10.1038/sj.bjc.6602496] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
45 Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 2009; 15(46): 5761-5769 [PMID: 19998495 DOI: 10.3748/wjg.15.5761] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 100] [Article Influence: 7.2] [Reference Citation Analysis]
46 Yuan L, Li ZW. Involvement of the PD-1/PD-L pathway in outcome of hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2011; 19(10): 1051-1056 [DOI: 10.11569/wcjd.v19.i10.1051] [Reference Citation Analysis]
47 Li W, She R, Liu L, You H, Yin J. Prevalence of a virus similar to human hepatitis B virus in swine. Virol J. 2010;7:60. [PMID: 20233455 DOI: 10.1186/1743-422x-7-60] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
48 Fan J, Huang X, Chen J, Cai Y, Xiong L, Mu L, Zhou L. Host Genetic Variants in HLA Loci Influence Risk for Hepatitis B Virus Infection in Children. Hepat Mon 2016;16:e37786. [PMID: 27795724 DOI: 10.5812/hepatmon.37786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tang XR, Zhang JS, Zhao H, Gong YH, Wang YZ, Zhao JL. Detection of hepatitis B virus genotypes using oligonucleotide chip among hepatitis B virus carriers in Eastern China. World J Gastroenterol 2007; 13(13): 1975-1979 [PMID: 17461500 DOI: 10.3748/wjg.v13.i13.1975] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
50 Weng L, Du J, Zhou Q, Cheng B, Li J, Zhang D, Ling C. Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection. Mol Cancer. 2012;11:39. [PMID: 22682366 DOI: 10.1186/1476-4598-11-39] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
51 Tam YJ, Allaudin ZN, Lila MA, Bahaman AR, Tan JS, Rezaei MA. Enhanced cell disruption strategy in the release of recombinant hepatitis B surface antigen from Pichia pastoris using response surface methodology. BMC Biotechnol 2012;12:70. [PMID: 23039947 DOI: 10.1186/1472-6750-12-70] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
52 Lin LT, Wu SJ, Lin CC. The Anticancer Properties and Apoptosis-inducing Mechanisms of Cinnamaldehyde and the Herbal Prescription Huang-Lian-Jie-Du-Tang ( Huáng Lián Jiě Dú Tang) in Human Hepatoma Cells. J Tradit Complement Med 2013;3:227-33. [PMID: 24716182 DOI: 10.4103/2225-4110.119732] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
53 Hu Z, Zhou J, Wang H, Zhang M, Li S, Huang Y, Wu J, Li Z, Zhou L, Zheng S. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS One. 2013;8:e61620. [PMID: 23613886 DOI: 10.1371/journal.pone.0061620] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
54 Hou J, Wang G, Wang F, Cheng J, Ren H, Zhuang H, Sun J, Li L, Li J, Meng Q, Zhao J, Duan Z, Jia J, Tang H, Sheng J, Peng J, Lu F, Xie Q, Wei L; Chinese Society of Hepatology, Chinese Medical Association., Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). J Clin Transl Hepatol 2017;5:297-318. [PMID: 29226097 DOI: 10.14218/JCTH.2016.00019] [Cited by in Crossref: 109] [Cited by in F6Publishing: 59] [Article Influence: 21.8] [Reference Citation Analysis]
55 Sharon A, Chu CK. Understanding the molecular basis of HBV drug resistance by molecular modeling. Antiviral Res 2008;80:339-53. [PMID: 18765256 DOI: 10.1016/j.antiviral.2008.07.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
56 Maklad S, Reyad EM, William EA, Abouzeid A. Efficacy and Safety of Entecavir 0. 5 mg in Treating Naive Chronic Hepatitis B Virus Patients in Egypt: Five Years of Real Life Experience. Gastroenterology Res 2018;11:138-44. [PMID: 29707081 DOI: 10.14740/gr965w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 Fok BS, Gardner S, Piscitelli S, Chen S, Chu TT, Chan JC, Tomlinson B. Pharmacokinetic Properties of Single-Dose Lamivudine/Adefovir Dipivoxil Fixed-Dose Combination in Healthy Chinese Male Volunteers. Clinical Therapeutics 2013;35:68-76. [DOI: 10.1016/j.clinthera.2012.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, Chen X, Wang Y, Tang H. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep 2015;5:8421. [PMID: 25672227 DOI: 10.1038/srep08421] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 10.4] [Reference Citation Analysis]
59 Chipetah F, Chirambo A, Billiat E, Shawa IT. Hepatitis B virus seroprevalence among Malawian medical students: A cross-sectional study. Malawi Med J 2017;29:29-31. [PMID: 28567193 DOI: 10.4314/mmj.v29i1.6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Zhao Y, Gou XJ, Dai JY, Peng JH, Feng Q, Sun SJ, Cao HJ, Zheng NN, Fang JW, Jiang J, Su SB, Liu P, Hu YY, Zhang YY. Differences in metabolites of different tongue coatings in patients with chronic hepatitis B. Evid Based Complement Alternat Med 2013;2013:204908. [PMID: 23690837 DOI: 10.1155/2013/204908] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
61 Liu Y, Guo X, Wu L, Yang M, Li Z, Gao Y, Liu S, Zhou G, Zhao J. Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression. Oncotarget 2016;7:63856-69. [PMID: 27588480 DOI: 10.18632/oncotarget.11697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
62 Kim YJ, Kim K, Hwang SH, Kim SS, Lee D, Cheong JY, Cho SW. Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients. Clin Mol Hepatol. 2013;19:300-304. [PMID: 24133668 DOI: 10.3350/cmh.2013.19.3.300] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
63 Das T, Diamond DL, Yeh M, Hassan S, Bryan JT, Reyes JD, Perkins JD. Molecular Signatures of Recurrent Hepatocellular Carcinoma Secondary to Hepatitis C Virus following Liver Transplantation. J Transplant 2013;2013:878297. [PMID: 24377043 DOI: 10.1155/2013/878297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
64 Zhou R, Zhou YP, Lin C, Gao HB, Huang SW, Huang ZX, Sun F, Lin Y, Zhang DQ, Lin QF, Ao W, Pan C. Baseline prognostic factors and statistic model to predict early virological response in telbivudine-treated patients with chronic hepatitis B. Hepat Mon 2013;13:e15573. [PMID: 24403918 DOI: 10.5812/hepatmon.15573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
65 Cheng JL, Wang XL, Yang SG, Zhao H, Wu JJ, Li LJ. Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients. World J Gastroenterol 2017; 23(15): 2802-2810 [PMID: 28487618 DOI: 10.3748/wjg.v23.i15.2802] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
66 English P. Should universal hepatitis B immunisation be introduced in the UK? Arch Dis Child. 2006;91:286-289. [PMID: 16551785 DOI: 10.1136/adc.2005.080028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
67 Song MJ, Song DS, Kim HY, Yoo SH, Bae SH, Choi JY, Yoon SK, Paik YH, Lee JS, Lee HW, Kim HJ. Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B. World J Gastroenterol 2012; 18(43): 6277-6283 [PMID: 23180949 DOI: 10.3748/wjg.v18.i43.6277] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
68 Lv GC, Ma WJ, Ying LJ, Jin X, Zheng L, Yang YD. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels. World J Gastroenterol 2010; 16(32): 4095-4099 [PMID: 20731026 DOI: 10.3748/wjg.v16.i32.4095] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
69 Nejo Y, Faneye AO, Olusola B, Bakarey S, Olayinka A, Motayo B; PERVI Study Group. Hepatitis B virus infection among sexually active individuals in Nigeria: a cross-sectional study. Pan Afr Med J 2018;30:155. [PMID: 30455784 DOI: 10.11604/pamj.2018.30.155.14886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
70 Yano Y, Seo Y, Azuma T, Hayashi Y. Hepatitis B virus and host factors. Hepatobiliary Surg Nutr. 2013;2:121-123. [PMID: 24570927 DOI: 10.3978/j.issn.2304-3881.2012.10.10] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
71 Zhang Y, Kang S, Fang W, Wu X, Liang W. Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation. Hepatobiliary Surg Nutr 2013;2:297-303. [PMID: 24570966 DOI: 10.3978/j.issn.2304-3881.2013.11.02] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
72 Wu HX, Andonov A, Giulivi A, Goedhuis NJ, Baptiste B, Furseth J, Poliquin D, Chan JI, Bolesnikov G, Moffat B, Paton S, Wu J. Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003. Int J Med Sci 2005;2:143-6. [PMID: 16239952 DOI: 10.7150/ijms.2.143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
73 Han GR, Xu CL, Zhao W, Yang YF. Management of chronic hepatitis B in pregnancy. World J Gastroenterol 2012; 18(33): 4517-4521 [PMID: 22969224 DOI: 10.3748/wjg.v18.i33.4517] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
74 Yang J, Zhao LS. Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report. Virol J 2009;6:97. [PMID: 19583877 DOI: 10.1186/1743-422X-6-97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Ezechi OC, Kalejaiye OO, Gab-Okafor CV, Oladele DA, Oke BO, Musa ZA, Ekama SO, Ohwodo H, Agahowa E, Gbajabiamilla T, Ezeobi PM, Okwuraiwe A, Audu R RA, Okoye RN, David AN, Odunukwe NN, Onwujekwe DI, Ujah IA. Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection. Pan Afr Med J 2014;17:197. [PMID: 25396023 DOI: 10.11604/pamj.2014.17.197.2310] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
76 Fourati S, Pawlotsky JM. Recent advances in understanding and diagnosing hepatitis B virus infection. F1000Res. 2016;5:pii: F1000. [PMID: 27635243 DOI: 10.12688/f1000research.8983.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
77 Khaled IA, Mahmoud OM, Saleh AF, Bioumie EE. Prevalence of HBV genotypes among Egyptian hepatitis patients. Mol Biol Rep 2011;38:4353-7. [PMID: 21181276 DOI: 10.1007/s11033-010-0562-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
78 Yuen MF, Lee SH, Kang HM, Kim CR, Kim J, Ngai V, Lai CL. Pharmacokinetics of LB80331 and LB80317 following oral administration of LB80380, a new antiviral agent for chronic hepatitis B (CHB), in healthy adult subjects, CHB patients, and mice. Antimicrob Agents Chemother 2009;53:1779-85. [PMID: 19223649 DOI: 10.1128/AAC.01290-08] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
79 Schwaneck EC, Krone M, Kreissl-Kemmer S, Weißbrich B, Weiss J, Tony HP, Gadeholt O, Schmalzing M, Geier A. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients. Clin Rheumatol 2018;37:2963-70. [PMID: 30238380 DOI: 10.1007/s10067-018-4295-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
80 Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008; 14(21): 3396-3402 [PMID: 18528937 DOI: 10.3748/wjg.14.3396] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
81 Shen XX, Qiu FZ, Shen LP, Yan TF, Zhao MC, Qi JJ, Chen C, Zhao L, Wang L, Feng ZS, Ma XJ. A rapid and sensitive recombinase aided amplification assay to detect hepatitis B virus without DNA extraction. BMC Infect Dis 2019;19:229. [PMID: 30836947 DOI: 10.1186/s12879-019-3814-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
82 Wang P, Tam N, Wang H, Zheng H, Chen P, Wu L, He X. Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis. PLoS One. 2014;9:e104480. [PMID: 25102072 DOI: 10.1371/journal.pone.0104480] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
83 He Y, Guo Y, Chen J, Hu X, Li X, Kong Y, Zhang X, Zhou X, Liu L, Hou J. Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study. J Cancer 2018;9:1385-93. [PMID: 29721048 DOI: 10.7150/jca.23725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Spackman DE, Veenstra DL. A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B. Pharmacoeconomics 2008;26:937-49. [PMID: 18850763 DOI: 10.2165/00019053-200826110-00006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
85 Waltz TL, Marras S, Rochford G, Nolan J, Lee E, Melegari M, Pollack H. Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals. J Clin Microbiol. 2005;43:254-258. [PMID: 15634980 DOI: 10.1128/JCM.43.1.254-258.2005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
86 Bafa TA, Egata AD. Seroepidemiological patterns and predictors of hepatitis B, C and HIV viruses among pregnant women attending antenatal care clinic of Atat Hospital, Southern Ethiopia. SAGE Open Med 2020;8:2050312119900870. [PMID: 32002184 DOI: 10.1177/2050312119900870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
87 Fung J, Lai CL, Yuen MF. Management of chronic hepatitis B in severe liver disease. World J Gastroenterol 2014; 20(43): 16053-16061 [PMID: 25473157 DOI: 10.3748/wjg.v20.i43.16053] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
88 Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma. World J Hepatol 2016; 8(10): 485-498 [PMID: 27057306 DOI: 10.4254/wjh.v8.i10.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
89 Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR; SIMTI study group for HBV infection among first-time blood donors. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus. 2013;11:281-288. [PMID: 23399361 DOI: 10.2450/2012.0160-12] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
90 Kondo Y, Shimosegawa T. Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs. Int J Mol Sci 2015;16:3307-22. [PMID: 25654227 DOI: 10.3390/ijms16023307] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
91 Zeremski M, Dimova RB, Benjamin S, Makeyeva J, Yantiss RK, Gambarin-Gelwan M, Talal AH. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B. BMC Gastroenterol 2014;14:118. [PMID: 24990385 DOI: 10.1186/1471-230X-14-118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
92 Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet 2008;35:255-64. [PMID: 18479293 DOI: 10.1111/j.1744-313X.2008.00770.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
93 Gu H, Yao J, Zhu W, Lv H, Cheng S, Ling L, Xia S, Chen Y. The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination. Hum Vaccin Immunother 2013;9:1292-5. [PMID: 23422028 DOI: 10.4161/hv.24021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Hoang JK, Yang HI, Le A, Nguyen NH, Lin D, Vu VD, Chaung K, Nguyen V, Trinh HN, Li J, Zhang JQ, Chen CJ, Nguyen MH. Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine (Baltimore) 2016;95:e4433. [PMID: 27495067 DOI: 10.1097/MD.0000000000004433] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
95 Sarin SK, Kumar M. Should chronic HBV infected patients with normal ALT treated: debate. Hepatol Int 2008;2:179-84. [PMID: 19669302 DOI: 10.1007/s12072-008-9065-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
96 Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 2013;8:e66920. [PMID: 23825586 DOI: 10.1371/journal.pone.0066920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
97 Kumamoto H, Fukano M, Imoto S, Kohgo S, Odanaka Y, Amano M, Kuwata-Higashi N, Mitsuya H, Haraguchi K, Fukuhara K. A novel entecavir analogue constructing with a spiro[2.4]heptane core structure in the aglycon moiety: Its synthesis and evaluation for anti-hepatitis B virus activity. Nucleosides Nucleotides Nucleic Acids 2017;36:463-73. [PMID: 28574799 DOI: 10.1080/15257770.2017.1322209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
98 Sun XY, Dong JH, Qin KE, Lan LG, Li HB, Huang Y, Cao S, Li ZJ, Dai LJ. Single-center study on transplantation of livers donated after cardiac death: A report of 6 cases. Exp Ther Med 2016;11:988-92. [PMID: 26998025 DOI: 10.3892/etm.2016.3001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
99 Marotel M, Villard M, Drouillard A, Tout I, Besson L, Allatif O, Pujol M, Rocca Y, Ainouze M, Roblot G, Viel S, Gomez M, Loustaud V, Alain S, Durantel D, Walzer T, Hasan U, Marçais A. Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion. Elife 2021;10:e60095. [PMID: 33507150 DOI: 10.7554/eLife.60095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
100 Lv H, Pan ZQ, Hu SY, Qiu LM. CD4+CD25+ regulatory T cells and different states of HBV infection. Shijie Huaren Xiaohua Zazhi 2014; 22(10): 1373-1377 [DOI: 10.11569/wcjd.v22.i10.1373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Riner DK, Ndombi EM, Carter JM, Omondi A, Kittur N, Kavere E, Korir HK, Flaherty B, Karanja D, Colley DG. Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid. PLoS Negl Trop Dis 2016;10:e0005180. [PMID: 27926921 DOI: 10.1371/journal.pntd.0005180] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
102 Ren FY, Piao DM, Piao XX. A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B. World J Gastroenterol 2007; 13(31): 4264-4267 [PMID: 17696259 DOI: 10.3748/wjg.v13.i31.4264] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
103 Ding Y, Wu FL, Sheng QJ, Zhao LR, Xia TT, Wang JY, Shi LL, Wang SL, Shan H, An P, Duan HY, Dou XG. Combination therapy with peginterferonα-2a and adefovir dipivoxil for HBeAg-positive chronic hepatitis B: A prospective multicenter cohort study. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2036-2042 [DOI: 10.11569/wcjd.v20.i22.2036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Ma Y, Yu J, Chan HL, Chen YC, Wang H, Chen Y, Chan CY, Go MY, Tsai SN, Ngai SM. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics. 2009;8:2582-2594. [PMID: 19671925 DOI: 10.1074/mcp.m900180-mcp200] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
105 Ma Y, Ding Y, Juan F, Dou XG. Genotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang, China. Virol J 2011;8:315. [PMID: 21693069 DOI: 10.1186/1743-422X-8-315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
106 Zidan A, Scheuerlein H, Schüle S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon. 2012;12:e6894. [PMID: 23233864 DOI: 10.5812/hepatmon.6894] [Cited by in Crossref: 17] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
107 Kondo Y, Ninomiya M, Kakazu E, Kimura O, Shimosegawa T. Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection. ISRN Gastroenterol. 2013;2013:935295. [PMID: 23401786 DOI: 10.1155/2013/935295] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
108 Chen ZH, Hong YF, Lin J, Li X, Wu DH, Wen JY, Chen J, Ruan DY, Lin Q, Dong M, Wei L, Wang TT, Lin ZX, Ma XK, Wu XY, Xu R. Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncol Lett 2017;14:705-14. [PMID: 28693224 DOI: 10.3892/ol.2017.6222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
109 Alshammari TM, Aljofan M, Subaie G, Hussain T. Knowledge, awareness, attitude, and practice of health-care professionals toward hepatitis B disease and vaccination in Saudi Arabia. Hum Vaccin Immunother 2019;15:2816-23. [PMID: 31226008 DOI: 10.1080/21645515.2019.1629255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Li F, Guo Z, Zhang Y, Wang H, Zhang X, Si T, Yu H, Qi L. Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study. Ir J Med Sci 2015;184:753-9. [PMID: 24972992 DOI: 10.1007/s11845-014-1164-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
111 Fang ZX, Niu JJ, Liu PG, Lin Y. Genome-wide long noncoding RNA and mRNA expression profiles demonstrate associations between exposure to inorganic elements and the risk of developing hepatocellular carcinoma. BMC Med Genomics 2021;14:85. [PMID: 33736645 DOI: 10.1186/s12920-021-00927-w] [Reference Citation Analysis]
112 Eskandari E, Dahmardeh T, Dahmardeh F, Pahlevani E, Metanat M. Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection. Virusdisease 2017;28:289-94. [PMID: 29291215 DOI: 10.1007/s13337-017-0391-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Alemu AA, Zeleke LB, Aynalem BY, Kassa GM. Hepatitis B Virus Infection and Its Determinants among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis. Infect Dis Obstet Gynecol 2020;2020:9418475. [PMID: 32577077 DOI: 10.1155/2020/9418475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
114 Kusama K, Nakae Y, Tada M, Higashiyama Y, Miyaji Y, Yamaura G, Kunii M, Tanaka K, Ohyama K, Koike H, Joki H, Doi H, Koyano S, Tanaka F. Hepatitis B Virus-related Vasculitic Neuropathy in an Inactive Virus Carrier Treated with Intravenous Immunoglobulin. Intern Med 2020;59:3075-8. [PMID: 32759579 DOI: 10.2169/internalmedicine.4498-20] [Reference Citation Analysis]
115 Li Y, Wan DF, Su JJ, Cao J, Ou C, Qiu XK, Ban KC, Yang C, Qin LL, Luo D, Yue HF, Zhang LS, Gu JR. Differential expression of genes during aflatoxin B1-induced hepatocarcinogenesis in tree shrews. World J Gastroenterol 2004; 10(4): 497-504 [PMID: 14966905 DOI: 10.3748/wjg.v10.i4.497] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
116 Sanjay ST, Dou M, Sun J, Li X. A paper/polymer hybrid microfluidic microplate for rapid quantitative detection of multiple disease biomarkers. Sci Rep 2016;6:30474. [PMID: 27456979 DOI: 10.1038/srep30474] [Reference Citation Analysis]
117 Calhan T, Sahin A, Kahraman R, Altunoz ME, Ozbakır F, Ozdil K, Sokmen HM. Antineutrophil cytoplasmic antibody frequency in chronic hepatitis B patients. Dis Markers 2014;2014:982150. [PMID: 25161336 DOI: 10.1155/2014/982150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
118 Chen EQ, Huang FJ, He LL, Bai L, Wang LC, Zhou TY, Lei XZ, Liu C, Tang H. Histological changes in chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal. Dig Dis Sci. 2010;55:432-437. [PMID: 19241166 DOI: 10.1007/s10620-009-0724-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
119 Wang YP, Liu F, He HW, Han YX, Peng ZG, Li BW, You XF, Song DQ, Li ZR, Yu LY, Cen S, Hong B, Sun CH, Zhao LX, Kreiswirth B, Perlin D, Shao RG, Jiang JD. Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus. Antimicrob Agents Chemother 2010;54:2070-7. [PMID: 20176893 DOI: 10.1128/AAC.01764-09] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
120 Wang L, Wang K, Zou ZQ. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. World J Hepatol 2015; 7(30): 2980-2991 [PMID: 26730277 DOI: 10.4254/wjh.v7.i30.2980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
121 Zhang YY, Chen EQ, Yang J, Duan YR, Tang H. Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis. Virol J. 2009;6:63. [PMID: 19467157 DOI: 10.1186/1743-422x-6-63] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
122 Njei B, Garg SK, Kenta-bibi E, Zhao P, Kongnyuy EJ; Cochrane Hepato-Biliary Group. Isoprinosine versus other antiviral drugs for chronic hepatitis B. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd010506] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
123 Du J, Xu Y, Wang J, Liu S, Liu Y, Zhang X, Xu E. 24 year outcomes of hepatitis B vaccination in Hangzhou, China. Hum Vaccin Immunother 2015;11:2051-60. [PMID: 25714188 DOI: 10.1080/21645515.2015.1008873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
124 Bracho MA, Gosalbes MJ, González F, Moya A, González-Candelas F. Molecular epidemiology and evolution in an outbreak of fulminant hepatitis B virus. J Clin Microbiol 2006;44:1288-94. [PMID: 16597853 DOI: 10.1128/JCM.44.4.1288-1294.2006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
125 Coffin CS, Fung SK, Ma MM; Canadian Association for the Study of the Liver. Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines. Can J Gastroenterol 2012;26:917-38. [PMID: 23248795 DOI: 10.1155/2012/506819] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
126 Sanjay ST, Dou M, Sun J, Li X. A paper/polymer hybrid microfluidic microplate for rapid quantitative detection of multiple disease biomarkers. Sci Rep 2016;6:30474. [PMID: 27456979 DOI: 10.1038/srep30474] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 13.0] [Reference Citation Analysis]
127 Li Z, Yao H, Ma Y, Dong Q, Chen Y, Peng Y, Zheng BJ, Huang JD, Chan CY, Lin MC, Sung JJ, Yuen KY, Kung HF, He ML. Inhibition of HBV gene expression and replication by stably expressed interferon-alpha1 via adeno-associated viral vectors. J Gene Med 2008;10:619-27. [PMID: 18383553 DOI: 10.1002/jgm.1174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
128 Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, Häussinger D. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut. 2005;54:1009-1013. [PMID: 15951551 DOI: 10.1136/gut.2004.060327] [Cited by in Crossref: 159] [Cited by in F6Publishing: 152] [Article Influence: 9.4] [Reference Citation Analysis]
129 Alvarado Esquivel C, Arreola Valenzuela MA, Mercado Suárez MF, Espinoza Andrade F. Hepatitis B virus infection among inpatients of a psychiatric hospital of Mexico. Clin Pract Epidemiol Ment Health 2005;1:10. [PMID: 16053524 DOI: 10.1186/1745-0179-1-10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
130 Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019;9:27-33. [PMID: 31988864 DOI: 10.5005/jp-journals-10018-1292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
131 Njei B, Kumar S, Kongnyuy EJ; Cochrane Hepato-Biliary Group. Adefovir dipivoxil for chronic hepatitis B. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd009521] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
132 Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
133 Gao Q, Shao D, Pan A, Gao M, Liu Z, Liang C. Noninvasive assessment of liver stiffness by transient elastography (FibroScan) in liver fluke disease. Eur J Gastroenterol Hepatol 2016;28:70-3. [PMID: 26529360 DOI: 10.1097/MEG.0000000000000500] [Reference Citation Analysis]
134 Yang ZJ, Tu MZ, Liu J, Wang XL, Jin HZ. Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B. World J Gastroenterol 2006; 12(44): 7192-7196 [PMID: 17131486 DOI: 10.3748/wjg.v12.i44.7192] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
135 Maklad S, Esmat G, Hassan E, Attalah M, Zeid AA. Liver Biopsy and FibroScan to Detect Early Histopathological Changes in Chronic HBV Patients Not Candidate for Treatment. Gastroenterology Res 2014;7:56-63. [PMID: 27785271 DOI: 10.14740/gr597w] [Reference Citation Analysis]
136 Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at Bahir Dar Armed Forces General Hospital, Ethiopia. BMC Res Notes 2015;8:737. [PMID: 26625733 DOI: 10.1186/s13104-015-1719-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
137 Hayashi F, Momoki C, Yuikawa M, Simotani Y, Kawamura E, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N, Ohfuji S, Fukusima W, Habu D. Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis. World J Gastroenterol 2012; 18(40): 5759-5770 [PMID: 23155318 DOI: 10.3748/wjg.v18.i40.5759] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
138 Shi M, Zhang Y, Zhu YH, Zhang J, Xu WJ. Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples. World J Gastroenterol 2008; 14(3): 479-483 [PMID: 18200674 DOI: 10.3748/wjg.14.479] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
139 Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver. 2016;10:332-339. [PMID: 27114433 DOI: 10.5009/gnl15257] [Cited by in Crossref: 225] [Cited by in F6Publishing: 255] [Article Influence: 45.0] [Reference Citation Analysis]
140 Carmel R, Sarrai M. Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies. Curr Hematol Rep 2006;5:23-33. [PMID: 16537043 DOI: 10.1007/s11901-006-0019-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
141 Argyris EG, Acheampong E, Wang F, Huang J, Chen K, Mukhtar M, Zhang H. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. Virology. 2007;367:440-451. [PMID: 17631933 DOI: 10.1016/j.virol.2007.06.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
142 Wang YZ, Wu GX, Luo LB, Chen M, Ruan LH. Oligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus. World J Gastroenterol 2007; 13(31): 4260-4263 [PMID: 17696258 DOI: 10.3748/wjg.v13.i31.4260] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
143 Srivastava S, Wong KF, Ong CW, Huak CY, Yeoh KG, Teh M, Luk JM, Salto-Tellez M. A morpho-molecular prognostic model for hepatocellular carcinoma. Br J Cancer. 2012;107:334-339. [PMID: 22713659 DOI: 10.1038/bjc.2012.230] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
144 Kondo Y, Ueno Y, Shimosegawa T. Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies. Clin J Gastroenterol 2009;2:71-9. [PMID: 26192169 DOI: 10.1007/s12328-009-0074-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
145 Hann HW, Gregory VL, Dixon JS, Barker KF. A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B: Lamivudine resistance. Hepatol Int. 2008;2:440-456. [PMID: 19669319 DOI: 10.1007/s12072-008-9105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Zhang Z, Li L, Tian Y, Xia J, Hao Y, Li X, Lu M, Yang D. HBsAg/HBsAb double positive hepatitis B virus infection model in vitro and in vivo. J Huazhong Univ Sci Technolog Med Sci 2009;29:575-9. [PMID: 19821089 DOI: 10.1007/s11596-009-0509-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Li HT, Yan JB, Li J, Zhou MH, Zhu XD, Zhang YX, Tien P. Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice. World J Gastroenterol 2005; 11(19): 2858-2863 [PMID: 15902719 DOI: 10.3748/wjg.v11.i19.2858] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
148 Ma Y, Yuan Y, Ma X, Tang B, Hu X, Feng J, Tian L, Ji Y, Dou X. Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy. Exp Ther Med 2016;12:847-53. [PMID: 27446286 DOI: 10.3892/etm.2016.3365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Xu Y, Wang X, Liu Z, Zhou C, Qi W, Jiao J, Yu F, Guo H, Zhao P, Wang J. Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial. BMC Gastroenterol 2017;17:102. [PMID: 28854883 DOI: 10.1186/s12876-017-0657-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
150 Yang S, Xing H, Wang Y, Hou J, Luo D, Xie Q, Ning Q, Ren H, Ding H, Sheng J, Wei L, Chen S, Fan X, Huang W, Pan C, Gao Z, Zhang J, Zhou B, Chen G, Wan M, Tang H, Wang G, Yang Y, Xu D, Dong P, Wang Q, Wang J, Bognar FA, Xu D, Cheng J. HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients. Virol J 2016;13:180. [PMID: 27793166 DOI: 10.1186/s12985-016-0640-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
151 Behzadi MA, Ziyaeyan M, Asaei S. Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran. Jundishapur J Microbiol 2014;7:e10127. [PMID: 25147713 DOI: 10.5812/jjm.10127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
152 Zhang XG, Miao J, Li MW, Jiang SP, Hu FQ, Du YZ. Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy. J Zhejiang Univ Sci B. 2008;9:506-510. [PMID: 18543406 DOI: 10.1631/jzus.b0820047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
153 Cheung PY, Zhang Q, Zhang YO, Bai GR, Lin MCM, Chan B, Fong CC, Shi L, Shi YF, Chun J, Kung HF, Yang M. Effect of WeiJia on carbon tetrachloride induced chronic liver injury. World J Gastroenterol 2006; 12(12): 1912-1917 [PMID: 16609998 DOI: 10.3748/wjg.v12.i12.1912] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
154 Sène D, Pol S, Piroth L, Goujard C, Dellamonica P, Moussali J, Rey D, Loustaud-Ratti V, Alric L, Chousterman M, Borsa-Lebas F, Boucher O, Séréni D, Cacoub P; GERMIVIC Study Group. Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study. Epidemiol Infect 2007;135:409-16. [PMID: 16863601 DOI: 10.1017/S0950268806006947] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
155 Sunbul M, Leblebicioglu H. Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey. World J Gastroenterol 2005; 11(13): 1976-1980 [PMID: 15800989 DOI: 10.3748/wjg.v11.i13.1976] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
156 Leng A, Li Y, Wangen KR, Nicholas S, Maitland E, Wang J. Hepatitis B discrimination in everyday life by rural migrant workers in Beijing. Hum Vaccin Immunother 2016;12:1164-71. [PMID: 27043963 DOI: 10.1080/21645515.2015.1131883] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
157 Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY, So TM. Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes. 2009;7:52. [PMID: 19500349 DOI: 10.1186/1477-7525-7-52] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
158 Hann HW, Gregory VL, Dixon JS, Barker KF. A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B : Lamivudine resistance. Hepatol Int 2008;2:440-56. [PMID: 19669319 DOI: 10.1007/s12072-008-9105-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
159 Chen MF, Lin Y, Xia YC, Sun C, Feng XM, Lu MJ, Yang DL, Wu J. Establishment and application of hepatitis B virus persistent replication model in IFNAR(-/-) mouse. J Huazhong Univ Sci Technolog Med Sci. 2013;33:392-397. [PMID: 23771666 DOI: 10.1007/s11596-013-1130-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
160 Kondo Y, Kimura O, Tanaka Y, Ninomiya M, Iwata T, Kogure T, Inoue J, Sugiyama M, Morosawa T, Fujisaka Y, Shimosegawa T. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells. J Virol 2015;89:7016-27. [PMID: 25926643 DOI: 10.1128/JVI.00716-15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
161 Ohki T, Sato K, Yamagami M, Ito D, Yamada T, Kawanishi K, Kojima K, Seki M, Toda N, Tagawa K. Efficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis. Clin Drug Investig 2015;35:751-9. [PMID: 26446004 DOI: 10.1007/s40261-015-0333-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
162 Suhail M, Abdel-Hafiz H, Ali A, Fatima K, Damanhouri GA, Azhar E, Chaudhary AG, Qadri I. Potential mechanisms of hepatitis B virus induced liver injury. World J Gastroenterol 2014; 20(35): 12462-12472 [PMID: 25253946 DOI: 10.3748/wjg.v20.i35.12462] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
163 Yin JH, Zhao J, Zhang HW, Xie JX, Li WP, Xu GZ, Shen J, Dong HJ, Zhang J, Wang L, Han JK, Wang HY, Cao GW. HBV genotype C is independently associated with cirrhosis in community-based population. World J Gastroenterol 2010; 16(3): 379-383 [PMID: 20082486 DOI: 10.3748/wjg.v16.i3.379] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
164 Bini EJ, Kritz S, Brown LS, Robinson J, Calsyn D, Alderson D, Tracy K, McAuliffe P, Smith C, Rotrosen J. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States. J Subst Abuse Treat. 2012;42:438-445. [PMID: 22035702 DOI: 10.1016/j.jsat.2011.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
165 Zhuo Y, Yang Y, Zhang M, Xu Y, Chen Z, Mu L, Tang X, Zhong Z, Chen J, Zhou L. Single Nucleotide Polymorphisms in IFN-γ Signaling Pathway Associated with Risk of Hepatitis B Virus Infection in Chinese Children. Can J Infect Dis Med Microbiol 2020;2020:8121659. [PMID: 32047575 DOI: 10.1155/2020/8121659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Han Z, Yin Y, Zhang Y, Ehrhardt S, Thio CL, Nelson KE, Bai X, Hou H. Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China. PLoS One 2017;12:e0178671. [PMID: 28575040 DOI: 10.1371/journal.pone.0178671] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
167 Lv G, Ying L, Ma WJ, Jin X, Zheng L, Li L, Yang Y. Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment. Virol J. 2010;7:207. [PMID: 20807412 DOI: 10.1186/1743-422X-7-207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
168 Wang Z, Wu XL, Zeng WZ, Xu H, Zhang Y, Qin JP, Jiang MD. Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment. Virol J 2011;8:388. [PMID: 21816062 DOI: 10.1186/1743-422X-8-388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
169 Ahn SH, Chun JY, Shin SK, Park JY, Yoo W, Hong SP, Kim SO, Han KH. Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B. Clin Mol Hepatol 2013;19:399-408. [PMID: 24459645 DOI: 10.3350/cmh.2013.19.4.399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
170 Wang T, Qin Y, Zhang J, Li X, Tong S, Zhao W, Zhang J. An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene. Virus Genes 2020;56:677-86. [PMID: 32840739 DOI: 10.1007/s11262-020-01787-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
171 Weng M, Zeng WZ, Wu XL, Zhang Y, Jiang MD, Wang Z, Zhou DJ, He X. Quantification of serum hepatitis B surface antigen in predicting the response of pegylated interferon alfa-2a in HBeAg-positive chronic hepatitis B with prior lamivudine exposure. Virol J 2013;10:277. [PMID: 24010768 DOI: 10.1186/1743-422X-10-277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
172 Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Metanat M, Khosravi S, Farrokh P. Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population. Hepat Mon 2016;16:e32427. [PMID: 27148384 DOI: 10.5812/hepatmon.32427] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
173 Cheng J, Han Y, Jiang JD. Establishment of drug-resistant HBV small-animal models by hydrodynamic injection. Acta Pharm Sin B 2014;4:270-6. [PMID: 26579395 DOI: 10.1016/j.apsb.2014.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
174 Loomba R, Rowley AK, Wesley R, Smith KG, Liang TJ, Pucino F, Csako G. Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis. Clin Gastroenterol Hepatol. 2008;6:696-700. [PMID: 18456569 DOI: 10.1016/j.cgh.2008.02.055] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
175 Choukèr A, Thiel M, Lukashev D, Ward JM, Kaufmann I, Apasov S, Sitkovsky MV, Ohta A. Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway. Mol Med 2008;14:116-23. [PMID: 18163162 DOI: 10.2119/2007-00075.Chouker] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
176 Liu R, Nicholas S, Leng A, Qian D, Maitland E, Wang J. The influencing factors of discrimination against recovered Coronavirus disease 2019 (COVID-19) patients in China: a national study. Hum Vaccin Immunother 2021;:1-9. [PMID: 34085898 DOI: 10.1080/21645515.2021.1913966] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S, Yüksel I, Üsküdar O, Köklü S. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011;25:162-5. [PMID: 21567462 DOI: 10.1002/jcla.20450] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
178 Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203 [PMID: 19437558 DOI: 10.3748/wjg.15.2190] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
179 Zhang J, Ma J, Wang H, Guo L, Li J. Serum microRNA-30c levels are correlated with disease progression in Xinjiang Uygur patients with chronic hepatitis B. Braz J Med Biol Res 2017;50:e6050. [PMID: 28492809 DOI: 10.1590/1414-431X20176050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
180 Olioso D, Boaretti M, Ligozzi M, Lo Cascio G, Fontana R. Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2007;26:43-50. [PMID: 17216291 DOI: 10.1007/s10096-006-0223-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
181 Christen V, Duong F, Bernsmeier C, Sun D, Nassal M, Heim MH. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol. 2007;81:159-165. [PMID: 17065208 DOI: 10.1128/jvi.01292-06] [Cited by in Crossref: 83] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
182 Cui J, Kang X, Dai Z, Huang C, Zhou H, Guo K, Li Y, Zhang Y, Sun R, Chen J, Li Y, Tang Z, Uemura T, Liu Y. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification. J Cancer Res Clin Oncol 2007;133:825-34. [PMID: 17516088 DOI: 10.1007/s00432-007-0224-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
183 Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Plym M, Pokornowski K, Yu CF, Angus P. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother. 2004;48:3498-3507. [PMID: 15328117 DOI: 10.1128/aac.48.9.3498-3507.2004] [Cited by in Crossref: 407] [Cited by in F6Publishing: 120] [Article Influence: 22.6] [Reference Citation Analysis]
184 Rajkumar J, Sekar M, Mitra S. Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13(30): 4103-4107 [PMID: 17696230 DOI: 10.3748/wjg.v13.i30.4103] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
185 Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S, Afari EA. Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. Pan Afr Med J 2016;25:7. [PMID: 28210375 DOI: 10.11604/pamj.supp.2016.25.1.6172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
186 Honda K, Seike M, Maehara SI, Tahara K, Anai H, Moriuchi A, Muro T. Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis. World J Gastroenterol 2012; 18(20): 2586-2590 [PMID: 22654459 DOI: 10.3748/wjg.v18.i20.2586] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
187 Kondo Y, Ueno Y, Ninomiya M, Tamai K, Tanaka Y, Inoue J, Kakazu E, Kobayashi K, Kimura O, Miura M, Yamamoto T, Kobayashi T, Igarashi T, Shimosegawa T. Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy. J Gastroenterol 2012;47:1323-35. [PMID: 22588246 DOI: 10.1007/s00535-012-0596-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
188 Sukriti S, Pati NT, Bose S, Hissar SS, Sarin SK. Impaired antigen processing and presentation machinery is associated with immunotolerant state in chronic hepatitis B virus infection. J Clin Immunol. 2010;30:419-425. [PMID: 20300807 DOI: 10.1007/s10875-010-9379-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
189 Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, Li H, Liu Z, Zhao J. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS One 2015;10:e0137881. [PMID: 26367459 DOI: 10.1371/journal.pone.0137881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
190 Zou H, Chen Y, Duan Z, Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PLoS One 2011;6:e26748. [PMID: 22053208 DOI: 10.1371/journal.pone.0026748] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
191 Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int 2016;10:602-5. [PMID: 26416085 DOI: 10.1007/s12072-015-9666-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
192 Wang RS, Zhang H, Zhu YF, Han B, Yang ZJ. Detection of YMDD mutants using universal template real-time PCR. World J Gastroenterol 2006; 12(8): 1308-1311 [PMID: 16534892 DOI: 10.3748/wjg.v12.i8.1308] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
193 Khadem-Ansari MH, Omrani MD, Rasmi Y, Ghavam A. Diagnostic validity of the chemiluminescent method compared to polymerase chain reaction for hepatitis B virus detection in the routine clinical diagnostic laboratory. Adv Biomed Res. 2014;3:116. [PMID: 24949287 DOI: 10.4103/2277-9175.133178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
194 Abera B, Adem Y, Yimer M, Mulu W, Zenebe Y, Mekonnen Z. Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia. Virol J 2017;14:21. [PMID: 28166829 DOI: 10.1186/s12985-017-0696-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
195 Wu X, Zhou J, Xie W, Ding H, Ou X, Chen G, Ma A, Xu X, Ma H, Xu Y, Liu X, Meng T, Wang L, Sun Y, Wang B, Kong Y, Ma H, You H, Jia J. Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study. Infect Drug Resist 2019;12:745-57. [PMID: 31015765 DOI: 10.2147/IDR.S185120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
196 Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15:5761-5769. [PMID: 19998495 DOI: 10.3748/wjg.15.5761.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Bae JH, Sohn JH, Lee HS, Park HS, Hyun YS, Kim TY, Eun CS, Jeon YC, Han DS. A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier. Clin Mol Hepatol. 2012;18:225-228. [PMID: 22893874 DOI: 10.3350/cmh.2012.18.2.225] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
198 Gao LL, Wang XY, Lin JS, Zhang YH, Li Y. Efficacies of β-L-D4A against hepatitis B virus in 2.2.15 cells. World J Gastroenterol 2008; 14(8): 1263-1267 [PMID: 18300355 DOI: 10.3748/wjg.14.1263] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
199 Fung J, Lai CL, Seto WK, Yuen MF. The use of transient elastography in the management of chronic hepatitis B. Hepatol Int. 2011;5:868-875. [PMID: 21695588 DOI: 10.1007/s12072-011-9288-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
200 Okuse C, Yotsuyanagi H, Yamada N, Ikeda H, Kobayashi M, Fukuda Y, Takahashi H, Matsunaga K, Matsumoto N, Okamoto M, Ishii T, Sato A, Koike K, Suzuki M, Itoh F. Changes in levels of hepatitis B virus markers in patients positive for low-titer hepatitis B surface antigen. Hepatol Res 2012;42:1236-40. [PMID: 23181539 DOI: 10.1111/j.1872-034X.2012.01039.x] [Reference Citation Analysis]
201 Bernieh B. Viral hepatitis in hemodialysis: An update. J Transl Int Med. 2015;3:93-105. [PMID: 27847896 DOI: 10.1515/jtim-2015-0018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
202 Shinkai N, Nojima M, Iio E, Matsunami K, Toyoda H, Murakami S, Inoue T, Ogawa S, Kumada T, Tanaka Y. High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues. J Gastroenterol 2018;53:883-9. [PMID: 29288305 DOI: 10.1007/s00535-017-1424-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
203 Tag-Adeen M, Omar MZ, Abd-Elsalam FM, Hasaneen A, Mohamed MA, Elfeky HM, Said EM, Abdul-Aziz B, Osman AH, Ahmed ES, Osman GS, Abdul-Samie T. Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including 5 noninvasive indexes. Medicine (Baltimore) 2018;97:e9781. [PMID: 29419671 DOI: 10.1097/MD.0000000000009781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
204 Sultana N, Tabassum S, Ullah Munshi S, Hossain M, Imam A. Nucleoside Analog-treated Chronic Hepatitis B Patients showed Reduced Expression of PECAM-1 Gene in Peripheral Blood Mononuclear Cells in Bangladesh. Euroasian J Hepatogastroenterol 2014;4:87-91. [PMID: 29699354 DOI: 10.5005/jp-journals-10018-1108] [Reference Citation Analysis]
205 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabtake S, Ito T. Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy. J Gastroenterol 2015;50:795-804. [DOI: 10.1007/s00535-014-1011-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
206 Kai K, Miyoshi A, Kitahara K, Masuda M, Takase Y, Miyazaki K, Noshiro H, Tokunaga O. Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status. Int J Hepatol 2012;2012:495950. [PMID: 23251807 DOI: 10.1155/2012/495950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]